Control of intra- and extra-cellular sulphydryl-disulphide balances with gold phosphine drugs: 31P nuclear magnetic resonance studies of human blood.

@article{Malik1980ControlOI,
  title={Control of intra- and extra-cellular sulphydryl-disulphide balances with gold phosphine drugs: 31P nuclear magnetic resonance studies of human blood.},
  author={N A Malik and Gabriel Otiko and Peter J. Sadler},
  journal={Journal of inorganic biochemistry},
  year={1980},
  volume={12 4},
  pages={
          317-22
        }
}
Contrasting reactions of the antiarthritic complexes ClAuPEt3 and ClAu(PEt3)2 with blood have been studied by 31P nmr spectroscopy. The monophosphine complex has two binding sites in erythrocytes, probably at the SH groups of glutathione and haemoglobin. The bis complex solidifies blood via a reductive denaturation of albumin, with the release of OPet3. 
33 Citations
The Protein Chemistry of Antiarthritic Gold(I) Thiolates and Related Complexes
Abstract Our laboratory has extensively examined the inorganic biochemistry of antiarthritic gold drugs and selected analogues, focusing on their protein chemistry. The reactions of oligomericExpand
1H-NMR Spectroscopy of Gold Drugs. High-Resolution Studies of β-D-Thioglucosetetraacetate Phosphine Complexes of Au(I)
1H-NMR data (11.74 Tesla) for the gold(I) complexes [R3P-Au-(2,3,4, 6-tetra-O-acetyl-1-thio-β-D-glucopyranosido-S)] (R = Et, Cyclohexyl, C6H5, p-CH3OC6H4) with sulfur coordination to gold, areExpand
Phosphines and metal phosphine complexes: Relationship of chemistry to anticancer and other biological activity
Current interest in the biological chemistry of phosphines and their metal complexes ranges from the widespread application of PH3 as a fumigant, to the clinical use of a Au(I)PEt3 complex as anExpand
Gold(I) efflux from auranofin-treated red blood cells. Evidence for a glutathione-gold-albumin metabolite.
TLDR
Glutathione, generated by in situ labeling, also effluxed and associated with the albumin and gold, providing the first direct evidence that the album in-gold-glutathion complex (AlbSAuSG) may be a circulating metabolite of auranofin formed after both of the original ligands of aurenofin are displaced. Expand
Reactions of triethylphosphine gold(I) complexes with heme proteins: novel spin-state changes in cytochrome b562, myoglobin, and hemoglobin.
TLDR
Two distinct kinetic steps were observed in the autoxidation of HbO2 and MbO2 that may involve the liberation of superoxide and the kinetics of the spin-state change of cyt b562 were too fast to measure by conventional methods. Expand
On the biological properties of alkynyl phosphine gold(I) complexes.
TLDR
A pilot study aimed at establishing the biological profile of alkynyl phosphine gold(I) complexes shows that the critical target enzyme thioredoxin reductase can be efficiently and selectively inhibited and that cysteine and selenocysteine residues are presumably the sites of molecular interaction with the enzyme. Expand
Thiol competition for Et3PAuS-albumin: a nonenzymatic mechanism for Et3PO formation.
TLDR
The 31P NMR chemical shifts of various thiolato(triethylphosphine)gold(I) complexes are correlated directly with the affinity of the thiols for gold and inversely with their pKSH values. Expand
Inhibition of erythrocyte selenium-glutathione peroxidase by auranofin analogues and metabolites.
TLDR
The effect of gold ligation on the inhibition of bovine erythrocyte selenium-glutathione peroxidase (GSH-Px) was examined and confirmed the previous postulate that Au(SG)2- is generated from AuSTg in the presence of excess glutathione. Expand
Control of oxidative damage in rheumatoid arthritis by gold(I)-thiolate drugs.
The roles of anti-arthritic gold(I)-thiolate drugs such as disodium aurothiomalate ('Myocrisin') in the modulation or promotion of oxygen radical-mediated oxidative damage in vivo are reviewed. InExpand
Reactivity of auranofin with selenols and thiols: implications for the anticancer activity of gold(I) compounds
The enzyme thioredoxin reductase (TrxR) is attracting much interest as a potential target for cancer therapy. The presence of a selenium atom in the catalytic site makes it sensitive to inhibition byExpand
...
1
2
3
4
...